Suppr超能文献

通过聚合物-肽共混物组成调节颗粒生物降解

Tuning particle biodegradation through polymer-peptide blend composition.

作者信息

Gunawan Sylvia T, Kempe Kristian, Such Georgina K, Cui Jiwei, Liang Kang, Richardson Joseph J, Johnston Angus P R, Caruso Frank

机构信息

ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, and the Department of Chemical and Biomolecular Engineering, The University of Melbourne , Parkville, Victoria 3010, Australia.

出版信息

Biomacromolecules. 2014 Dec 8;15(12):4429-38. doi: 10.1021/bm5012272. Epub 2014 Oct 31.

Abstract

We report the preparation of polymer-peptide blend replica particles via the mesoporous silica (MS) templated assembly of poly(ethylene glycol)-block-poly(2-diisopropylaminoethyl methacrylate-co-2-(2-(2-(prop-2-ynyloxy)ethoxy)ethoxy)ethyl methacrylate) (PEG45-b-P(DPA55-co-PgTEGMA4)) and poly(l-histidine) (PHis). PEG45-b-P(DPA55-co-PgTEGMA4) was synthesized by atom transfer radical polymerization (ATRP), and was coinfiltrated with PHis into poly(methacrylic acid) (PMA)-coated MS particles assembled from different peptide-to-polymer ratios (1:1, 1:5, 1:10, or 1:15). Subsequent removal of the sacrificial templates and PMA resulted in monodisperse, colloidally stable, noncovalently cross-linked polymer-peptide blend replica particles that were stabilized by a combination of hydrophobic interactions between the PDPA and the PHis, hydrogen bonding between the PEG and PHis backbone, and π-π stacking of the imidazole rings of PHis side chains at physiological pH (pH ∼ 7.4). The synergistic charge-switchable properties of PDPA and PHis, and the enzymatic degradability of PHis, make these particles responsive to pH and enzymes. In vitro studies, in simulated endosomal conditions and inside cells, demonstrated that particle degradation kinetics could be engineered (from 2 to 8 h inside dendritic cells) based on simple adjustment of the peptide-to-polymer ratio used.

摘要

我们报道了通过聚(乙二醇)-嵌段-聚(2-二异丙基氨基乙基甲基丙烯酸酯-co-2-(2-(2-(丙-2-炔氧基)乙氧基)乙氧基)乙基甲基丙烯酸酯)(PEG45-b-P(DPA55-co-PgTEGMA4))和聚(L-组氨酸)(PHis)在介孔二氧化硅(MS)模板化组装下制备聚合物-肽共混复制颗粒的方法。PEG45-b-P(DPA55-co-PgTEGMA4)通过原子转移自由基聚合(ATRP)合成,并与PHis共渗入由不同肽与聚合物比例(1:1、1:5、1:10或1:15)组装而成的聚(甲基丙烯酸)(PMA)包覆的MS颗粒中。随后去除牺牲模板和PMA,得到单分散、胶体稳定、非共价交联的聚合物-肽共混复制颗粒,这些颗粒在生理pH(pH ∼ 7.4)下通过PDPA与PHis之间的疏水相互作用、PEG与PHis主链之间的氢键以及PHis侧链咪唑环的π-π堆积而稳定。PDPA和PHis的协同电荷可切换特性以及PHis的酶促降解性使这些颗粒对pH和酶有响应。在体外研究中,在模拟内体条件和细胞内进行的实验表明,基于简单调整所用的肽与聚合物比例,可以设计颗粒的降解动力学(在树突状细胞内从2小时到8小时)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验